Juno Therapeutics
VerifiedIs a clinical-stage company, develops immunotherapies for the treatment of cancer.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$9.0b (Public information from Jan 2018)
Seattle Washington (HQ)
Deals in current and previous year:
No columns specified